Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

BACKGROUND: Cladribine tablets have recently become available in The Netherlands for patients with relapsing–remitting multiple sclerosis (RRMS) as a disease-modifying agent that reduces the frequency and severity of relapses and delays disability progression. OBJECTIVE: The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Michels, Renée Else, de Fransesco, Maria, Mahajan, Koshu, Hengstman, Gerald J. D., Schiffers, Krijn M. H., Budhia, Sangeeta, Harty, Gerard, Krol, Marieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885501/
https://www.ncbi.nlm.nih.gov/pubmed/31444659
http://dx.doi.org/10.1007/s40258-019-00500-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885501/
https://www.ncbi.nlm.nih.gov/pubmed/31444659
http://dx.doi.org/10.1007/s40258-019-00500-8

Ejemplares similares